Hart, X. M. http://orcid.org/0000-0002-6033-0189
Heesen, S.
Schmitz, C. N.
Dörfler, S.
Wedekind, D.
Gründer, G.
Hiemke, C.
Havemann-Reinecke, U.
Funding for this research was provided by:
Zentralinstitut für Seelische Gesundheit (ZI)
Article History
Received: 17 March 2022
Accepted: 13 September 2022
First Online: 7 October 2022
Declarations
:
: CH has received speaker’s fees from Otsuka. He is editor of PSIAC, a web-based platform analysing pharmacokinetic and dynamic drug interactions. The software is distributed by Springer Nature, Heidelberg, Germany. GG has served as a consultant for Allergan, Boehringer Ingelheim, Institute for Quality and Efficiency in Health Care (IQWiG), Janssen-Cilag, Lundbeck, Otsuka, Recordati, ROVI, Sage, and Takeda. He has served on the speakers’ bureau of Gedeon Richter, Janssen Cilag, Lundbeck, Otsuka, Recordati. He has received grant support from Boehringer Ingelheim, Lundbeck and Saladax. He is co-founder and/or shareholder of Mind and Brain Institute GmbH, Brainfoods GmbH, OVID Health Systems GmbH and MIND Foundation gGmbH. All authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: This study was conducted in accordance with the World Medical Association Declaration of Helsinki. Ethics approval and written informed consent were not required for this study.